TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

The San Francisco-based company said it had profit of $3.28 per share. The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for ...

Market News Wall Street closed lower on Tuesday as investors assessed economic data while anticipating a Fed rate cut in June. The Nasdaq Composite, the Dow and the S&P 500 ended in negative territory ...

HARRISBURG, Pa. (AP) — HARRISBURG, Pa. (AP) — Ollie's Bargain Outlet Holdings Inc. (OLLI) on Wednesday reported fiscal fourth-quarter profit of $68.6 million. On a per-share basis, the Harrisburg, ...

(MDWD) on Wednesday reported a loss of $3.9 million in its fourth quarter. The Yavne, Israel-based company said it had a loss of 36 cents ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — General Mills Inc. (GIS) on Wednesday reported fiscal third-quarter profit of $625.6 million. On a per-share basis, the Minneapolis-based company said it had net ...

J.Jill Inc. (JILL) on Wednesday reported fiscal fourth-quarter profit of $2.2 million. The Quincy, Massachusetts-based company said it had profit of 14 ...

Analysts at Zacks Research lifted their Q1 2025 earnings estimates for shares of American Water Works in a research report ...

Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories ...

BROOMFIELD, Colo. (AP) — BROOMFIELD, Colo. (AP) — Gogo Inc. (GOGO) on Friday reported a loss of $28.2 million in its fourth quarter. On a per-share basis, the Broomfield, Colorado-based company said ...

SOUTH SAN FRANCISCO, Calif. (AP) — ...